TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 12.424
EU - Europa 4.804
AS - Asia 3.767
SA - Sud America 782
AF - Africa 230
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.019
Nazione #
US - Stati Uniti d'America 12.267
IT - Italia 1.562
RU - Federazione Russa 1.371
SG - Singapore 1.131
CN - Cina 921
BR - Brasile 644
VN - Vietnam 452
IE - Irlanda 440
HK - Hong Kong 381
KR - Corea 281
DE - Germania 238
FR - Francia 234
GB - Regno Unito 215
FI - Finlandia 169
BD - Bangladesh 160
SE - Svezia 147
ZA - Sudafrica 135
IN - India 130
NL - Olanda 123
CA - Canada 85
ES - Italia 49
PL - Polonia 45
MX - Messico 42
IQ - Iraq 40
AT - Austria 39
UA - Ucraina 38
AR - Argentina 36
JP - Giappone 30
TR - Turchia 29
CO - Colombia 27
EC - Ecuador 26
CI - Costa d'Avorio 24
CZ - Repubblica Ceca 24
ID - Indonesia 21
SA - Arabia Saudita 19
EG - Egitto 18
CH - Svizzera 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
KE - Kenya 16
LT - Lituania 15
MY - Malesia 14
PK - Pakistan 14
BE - Belgio 13
JO - Giordania 13
VE - Venezuela 13
PE - Perù 12
IR - Iran 11
MA - Marocco 11
CL - Cile 10
PY - Paraguay 9
AU - Australia 8
BG - Bulgaria 7
IL - Israele 7
NG - Nigeria 7
PH - Filippine 7
PT - Portogallo 7
BH - Bahrain 6
CR - Costa Rica 6
GE - Georgia 6
PS - Palestinian Territory 6
AL - Albania 5
AZ - Azerbaigian 5
ET - Etiopia 5
HR - Croazia 5
JM - Giamaica 5
KZ - Kazakistan 5
LK - Sri Lanka 5
LU - Lussemburgo 5
LV - Lettonia 5
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
SV - El Salvador 4
TH - Thailandia 4
YE - Yemen 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
DZ - Algeria 3
GR - Grecia 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
FJ - Figi 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 21.992
Città #
Dallas 9.451
Singapore 693
Moscow 453
Dublin 423
Hefei 385
Hong Kong 354
Ashburn 310
San Jose 301
Milan 295
Santa Clara 285
Seoul 280
Ho Chi Minh City 173
Los Angeles 160
Florence 155
Beijing 142
Siena 141
Council Bluffs 134
Chandler 116
Johannesburg 115
Helsinki 102
New York 100
The Dalles 96
Lauterbourg 94
Southend 87
Munich 86
Hanoi 83
Rome 77
Chicago 63
São Paulo 62
Bengaluru 56
Fairfield 54
Buffalo 49
Nuremberg 46
Orem 45
Princeton 43
Shanghai 35
Brescia 34
Lappeenranta 34
London 32
Frankfurt am Main 31
Montreal 29
Turku 29
Rio de Janeiro 25
Tokyo 25
Abidjan 24
Seattle 24
Warsaw 24
Naples 23
Da Nang 22
Redondo Beach 22
Houston 21
Toronto 21
Paris 20
Vienna 20
Bologna 19
Denver 19
Brasília 18
Portsmouth 18
Stockholm 18
Woodbridge 18
Boardman 17
Gdynia 17
Chennai 16
Curitiba 16
Düsseldorf 16
Hải Dương 16
Wilmington 16
Baghdad 15
Haiphong 15
Jacksonville 15
Málaga 15
Tashkent 15
Turin 15
Washington 15
Boston 14
Brooklyn 14
Mexico City 14
Brussels 13
Cape Town 13
Catania 13
Zurich 13
Amman 12
Amsterdam 12
Atlanta 12
Belo Horizonte 12
Cairo 12
Poplar 12
San Diego 12
Brno 11
Figline Valdarno 11
Guangzhou 11
Mumbai 11
Palermo 11
Phoenix 11
Comun Nuovo 10
Fremont 10
Genoa 10
Messina 10
Newark 10
Piscataway 10
Totale 16.637
Nome #
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 7.239
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 629
A first update on mapping the human genetic architecture of COVID-19 579
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 509
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 410
An explainable model of host genetic interactions linked to COVID-19 severity 368
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 349
Pathogen-sugar interactions revealed by universal saturation transfer analysis 349
null 320
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 309
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 300
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 300
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 295
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 283
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 272
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 254
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 243
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 236
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 216
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 213
Whole-genome sequencing reveals host factors underlying critical COVID-19 201
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses 187
Colonizzazione da batteri multiresistenti nel trapianto di polmone ed eventi infettivi: studio pilota osservazionale-retrospettivo 187
ACKNOWLEDGEMENT OF REVIEWERS 183
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 182
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 171
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 171
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 169
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: a retrospective observational multicenter study 165
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 164
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 156
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 155
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 153
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 150
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 148
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 147
PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests” 144
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 144
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 144
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study 144
Trattamento efficace di osteomielite sternale con raccolta purulenta da Klebsiella pneumoniae multiresistente in recente trapianto di polmone 144
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 143
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 141
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 141
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 140
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 139
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 132
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 132
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 132
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 131
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 127
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 126
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 124
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 122
Rapid Decrease in Fluoroquinolones Consumption following Implementation of a Simple Antimicrobial Stewardship Bundled Intervention in a University Hospital during the COVID-19 Pandemic 120
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 120
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 118
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 116
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 116
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 112
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 110
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 109
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 107
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 107
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 104
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 101
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 98
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 94
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment 92
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 91
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 90
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 87
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin? 85
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 83
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae 82
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 79
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 77
Use of colistin in adult patients: A cross-sectional study 76
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 76
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review 76
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 75
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 72
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area 70
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 70
Identification of two anti-Candida antibodies associated with the survival of patients with candidemia 69
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 67
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 67
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study 66
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients 65
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 63
SARS-CoV-2 infection in a highly experienced person living with HIV 60
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 53
Can we lower the burden of antimicrobial resistance (AMR) in heavily immunocompromised patients? A narrative review and call to action 50
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 46
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 29
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 26
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature 15
Diagnostic challenges in Flaviviridae infections: first human case of Usutu virus aseptic meningitis in an immunocompetent subject in Italy 14
Machine learning approaches to dissect hybrid and vaccine-induced immunity 13
Large, protracted, multi-species and multi-clonal spread of VIM-type metallo-β-lactamase-producing Enterobacterales in an Italian hospital 9
Totale 22.337
Categoria #
all - tutte 56.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 5 3
2021/2022310 15 9 2 8 4 3 31 57 13 26 53 89
2022/2023773 38 82 91 65 36 109 98 85 56 34 59 20
2023/20241.021 48 34 101 65 52 197 292 53 10 40 43 86
2024/20253.486 149 98 250 144 452 204 337 203 244 206 344 855
2025/202616.599 568 3.313 7.173 1.228 1.372 309 993 281 318 549 495 0
Totale 22.364